SCHEMBL1839990

SCHEMBL1839990

CCNc1nn2ccccc2c1[N+](=O)[O-]

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.43
MAPT P10636 9/20 0.43
HPGD P15428 4/20 0.39
GAA P10253 2/20 0.38
HTT P42858 3/20 0.37
NPC1 O15118 2/20 0.37
LMNA P02545 2/20 0.37
RAB9A P51151 2/20 0.37
NPSR1 Q6W5P4 2/20 0.37
TLR9 Q9NR96 2/20 0.37
MITF O75030 2/20 0.37
AGTR1 P30556 1/20 0.37
POLB P06746 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
XBP1 P17861 1/20 0.37
PAX8 Q06710 1/20 0.37
ATM Q13315 1/20 0.36
PGK1 P00558 1/20 0.36
EGFR P00533 1/20 0.36
GSK3A P49840 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3836284 0.89 LCK (0.40) ALDH1A1MAPTHPGDGAAHTT
SCHEMBL13646806 0.88 MAPT (0.40) ALDH1A1MAPTHPGDGAAHTT
SCHEMBL1841026 0.83 KAT2B (0.46) ALDH1A1MAPTHPGDGAAHTT
SCHEMBL1843356 0.83 MAPT (0.47) ALDH1A1MAPTGAANPC1POLB
SCHEMBL3835744 0.83 ALDH1A1 (0.50) ALDH1A1MAPTGAALMNANPSR1
SCHEMBL3841469 0.83 MAPT (0.34) ALDH1A1MAPTHPGDGAAHTT
SCHEMBL1843677 0.83 ALDH1A1 (0.40) ALDH1A1MAPTHPGDLMNANPSR1
SCHEMBL13714439 0.82 ALDH1A1 (0.34) ALDH1A1MAPTHPGDGAAHTT
SCHEMBL13714356 0.81 ALDH1A1 (0.37) ALDH1A1MAPTHPGDGAAHTT
SCHEMBL3835731 0.81 ALDH1A1 (0.45) ALDH1A1MAPTNPC1RAB9APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1977794-B Composition comprising at least one 3-amino-pyrazolopyridine derivatives OREAL 2014-09-03 CN disclosed
EP-1792606-B1 Composition for dyeing keratinic fibers comprising at least one derivative of 3-amino pyrazolopyridine OREAL (FR) 2011-05-18 EP disclosed
US-7857864-B2 Composition for the dyeing of keratin fibers comprising at least one 3-amino-pyrazolopyridine derivative L'OREAL S.A. (FR) 2010-12-28 US disclosed
US-7857864-B2 Composition for the dyeing of keratin fibers comprising at least one 3-amino-pyrazolopyridine derivative L'OREAL S.A. (FR) 2010-12-28 US disclosed
US-20100115711-A1 COMPOSITION FOR THE DYEING OF KERATIN FIBERS COMPRISING AT LEAST ONE 3-AMINO-PYRAZOLOPYRIDINE DERIVATIVE L'OREAL S.A. (FR) 2010-05-13 US disclosed
US-20100115711-A1 COMPOSITION FOR THE DYEING OF KERATIN FIBERS COMPRISING AT LEAST ONE 3-AMINO-PYRAZOLOPYRIDINE DERIVATIVE L'OREAL S.A. (FR) 2010-05-13 US disclosed
US-7635394-B2 Composition for the dyeing of keratin fibers comprising at least one 3-amino-pyrazolopyridine derivatives L'OREAL S.A. (FR) 2009-12-22 US disclosed
US-7635394-B2 Composition for the dyeing of keratin fibers comprising at least one 3-amino-pyrazolopyridine derivatives L'OREAL S.A. (FR) 2009-12-22 US disclosed
US-20070143935-A1 Composition for the dyeing of keratin fibers comprising at least one 3-amino-pyrazolopyridine derivatives L'OREAL S.A. (FR) 2007-06-28 US disclosed
US-20070143935-A1 Composition for the dyeing of keratin fibers comprising at least one 3-amino-pyrazolopyridine derivatives L'OREAL S.A. (FR) 2007-06-28 US disclosed
CN-1977794-A Composition comprising at least one 3-amino-pyrazolopyridine derivatives OREAL (FR) 2007-06-13 CN disclosed
EP-1792606-A1 Composition for dyeing keratinic fibers comprising at least one derivative of 3-amino pyrazolopyridine L'Oréal (FR) 2007-06-06 EP disclosed
EP-1792606-A1 Composition for dyeing keratinic fibers comprising at least one derivative of 3-amino pyrazolopyridine L'Oréal (FR) 2007-06-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070143935-A1 Composition for the dyeing of keratin fibers comprising at least one 3-amino-pyrazolopyridine derivatives KRT18, MARK1, MARK2 ALDH1A1 683/4885MAPT 1134/4885HPGD 401/4885
US-20100115711-A1 COMPOSITION FOR THE DYEING OF KERATIN FIBERS COMPRISING AT LEAST ONE 3-AMINO-PYRAZOLOPYRIDINE DERIVATIVE KRT18, MARK1, MARK2 ALDH1A1 711/4885MAPT 1157/4885HPGD 387/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.